Status: Not yet recruiting
The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers
This is a single dose, randomized, open-label, two-way crossover study to investigate the food-effect bioavailability of the fixed-dose combination of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg in healthy volunteers under fasting and fed conditions.
Participants needed: 28
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: LG ChemUpdated: Apr 13, 2026Locations: 1
Eligibility criteria
Healthy Thai male and female subjects between the ages of 18 to 55 years. [+6]
History of allergic reaction or hypersensitivity to gemigliptin or dapagliflozin... [+6]